Novartis Pharma GmbH
PolandAll medications by this manufacturer
-
Desferal
Form: powder for preparation of injection solution
Active substance Dosage Deferoxamine mesylate 500 mg ATC: V03AC01
-
Desferal
Form: powder for preparation of injection solution
Active substance Dosage Deferoxamine mesylate 500 mg ATC: V03AC01
-
Inzolfi
Form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
Inzolfi
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.28 mg ATC: L04AA27
-
Lioresal intrathecal 10 mg/20 ml
Form: solution for infusion
Active substance Dosage baclofen 10 mg/20 ml ATC: M03BX01
-
Lioresal intrathecal 10 mg/20 ml
Form: solution for infusion
Active substance Dosage baclofen 10 mg/20 ml ATC: M03BX01
-
Lioresal intrathecal 10 mg/5 ml
Form: solution for infusion
Active substance Dosage baclofen 10 mg/5 ml ATC: M03BX01
-
Maxitrol
Form: drops, ophthalmic suspension
Active substance Dosage dexamethasone 1 mg/ml neomycin 3500 j.m./ml polymyxin B 6000 j.m./ml ATC: S01CA01
-
Maxitrol
Form: drops, ophthalmic suspension
Active substance Dosage dexamethasone 1 mg neomycin 3500 j.m. polymyxin B 6000 j.m. ATC: S01CA01
-
Maxitrol
Form: drops, ophthalmic suspension
Active substance Dosage dexamethasone 1 mg/ml neomycin 3500 j.m./ml polymyxin B 6000 j.m./ml ATC: S01CA01
-
Tobradex
Form: drops, ophthalmic suspension
Active substance Dosage Dexamethasone 1 mg/ml Tobramycin 3 mg/ml ATC: S01CA01
-
Tobrex
Form: ointment, for eyes
ATC: S01AA12